Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Bottom up proteomics identifies neuronal differentiation pathway networks activated by cathepsin inhibition treatment in neuroblastoma cells that are enhanced by concurrent 13-cis retinoic acid treatment

Journal of Proteomics(2020)10.1016/j.jprot.2020.104068Source: DataRank Database

Bottom up proteomics identifies neuronal differentiation pathway networks activated by cathepsin inhibition treatment in neuroblastoma cells that are enhanced by concurrent 13-cis retinoic acid treatment is a research paper published in Journal of Proteomics (2020). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.17)OA: greenTopics (41)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Andrew J. Connell ORCID,Lisa Glazewski,Shuo Wei ORCID,Robert W. Mason,Effie G. Halakos

Live enrichment

PubMed:33278663 OpenAlex:https://openalex.org/W3107426640

National Institute of General Medical Sciences

Grant: P30GM104316

National Institute of General Medical Sciences

Grant: P30GM110758

National Institute of General Medical Sciences

Grant: P30GM114736

National Institute of General Medical Sciences

Grant: R01GM114105

National Institutes of Health

Grant: 5P30GM114736-03

Center for Pediatric Research (CPR)

National Institutes of Health

Grant: 5P30GM110758-04

Molecular Design of Advanced Biomaterials

National Institutes of Health

Grant: 5R01GM114105-04

A conserved ADAM-ephrin-Wnt signaling axis in neural crest development and cancer

FWCI

0.17

Citation Percentile

0.5%

Citation Trend

2022

2024

2025

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7814974

publisherhttps://api.elsevier.com/content/article/PII:S187439192030436X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S187439192030436X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jprot.2020.104068

Fields of Study

Neuroblastoma Research and TreatmentsUbiquitin and proteasome pathwaysCell death mechanisms and regulation0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

CathepsinsCell DifferentiationChildHumansNeuroblastomaTretinoinIsotretinoinProteomics

Keywords

NeuroblastomaRetinoic acidNeuriteCancer researchCathepsin DProteomicsCathepsinCellular differentiationBiologyPediatric cancerDifferentiation therapyCell biologyMolecular biologyMedicineInternal medicineCancerBiochemistryEnzymeCell cultureGeneGeneticsHumansCell DifferentiationTretinoinChildIsotretinoinCathepsins

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being